New supercharged CAR-T cell therapy shows promise against resistant cancers
Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized cancer treatment by engineering a patient’s T-cells to target and eliminate malignant cells. However, certain cancers still evade detection, leading to treatment resistance and relapse. American researchers have recently introduced an innovative approach known as ALA-CART (adjunctive LAT-activating CAR-T cells), designed to overcome these challenges. In preclinical […]
